Nature's Sunshine Products Inc. (NATR) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, NATR trades at $21.93 with a market cap of $391.26M and a P/E ratio of 19.92. NATR moved +1.25% today. Year to date, NATR is +2.67%; over the trailing twelve months it is +49.59%. Its 52-week range spans $11.01 to $28.14. Analyst consensus is buy with an average price target of $37.00. Rallies surfaces NATR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nature’s Sunshine Net Sales Rise 9% to $122.9M, Adjusted EBITDA Up 33%: Nature’s Sunshine first-quarter net sales rose 9% year-over-year to $122.9 million, with gross profit margin improving 116 basis points to 73.2%. GAAP net income reached $5.1 million, or $0.29 per share (up 16%), while adjusted EBITDA climbed 33% to $14.6 million.
| Metric | Value |
|---|---|
| Price | $21.93 |
| Market Cap | $391.26M |
| P/E Ratio | 19.92 |
| EPS | $1.11 |
| Dividend Yield | 1.00% |
| 52-Week High | $28.14 |
| 52-Week Low | $11.01 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $489.79M |
| Net Income | $20.68M |
| Gross Margin | 72.71% |
2 analysts cover NATR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $37.00.